- Report
- March 2024
- 199 Pages
Global
From €3205EUR$3,374USD£2,749GBP
€3562EUR$3,749USD£3,054GBP
- Report
- May 2024
- 186 Pages
Global
From €3205EUR$3,374USD£2,749GBP
€3562EUR$3,749USD£3,054GBP
- Report
- January 2024
- 150 Pages
Global
From €5653EUR$5,950USD£4,847GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Report
- May 2024
- 194 Pages
Global
From €4703EUR$4,950USD£4,032GBP
- Report
- October 2023
- 150 Pages
Global
From €2374EUR$2,499USD£2,036GBP
- Report
- February 2024
- 188 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2850EUR$3,000USD£2,444GBP
- Report
- April 2024
- 152 Pages
Global
From €3753EUR$3,950USD£3,218GBP
- Report
- June 2023
- 200 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- October 2023
- 190 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,073GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Report
- February 2024
- 110 Pages
Global
From €4513EUR$4,750USD£3,870GBP
- Report
- March 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,381GBP
- Report
- April 2022
- 191 Pages
Global
From €3026EUR$3,185USD£2,595GBP
€4323EUR$4,550USD£3,707GBP
- Report
- April 2023
- 240 Pages
Global
From €3325EUR$3,500USD£2,851GBP
- Report
- April 2023
- 115 Pages
Global
From €4513EUR$4,750USD£3,870GBP
- Report
- June 2022
- 95 Pages
Global
From €3753EUR$3,950USD£3,218GBP
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more